Autolus Therapeutics (AUTL) announced the appointment of Ryan Richardson to the Company’s Board of Directors. Richardson previously served as Chief Strategy Officer and member of the Management Board of BioNTech during his tenure from September 2018 to September 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Midday Fly By: Alphabet continues ascent, fueled by AI optimism
- Autolus Therapeutics announces NICE draft guidance recommending Aucatzyl
- Autolus Therapeutics Reports Q3 2025 Financial Results
- Autolus Therapeutics’ Earnings Call: Mixed Sentiments
- Autolus Therapeutics: Strong Buy Rating Backed by Growth Potential and Strategic Advancements